Evidence map›Paper›PMID 24475092›Full record

ArticlePloS one2014

Regulation of PP2AC carboxylmethylation and cellular localisation by inhibitory class G-protein coupled receptors in cardiomyocytes.

Michael R Longman, Antonella Ranieri, Metin Avkiran, Andrew K Snabaitis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. The Angiotensin ATPharmacological reviews · 2022
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Michael R LongmanSchool of Pharmacy and Chemistry, Faculty of Science, Engineering and Computing, Kingston University, Kingston-upon-Thames, Surrey, United Kingdom.
Antonella RanieriKing's College London British Heart Foundation Centre, Cardiovascular Division, The Rayne Institute, St Thomas' Hospital, London, United Kingdom.
Metin AvkiranKing's College London British Heart Foundation Centre, Cardiovascular Division, The Rayne Institute, St Thomas' Hospital, London, United Kingdom.
Andrew K SnabaitisSchool of Pharmacy and Chemistry, Faculty of Science, Engineering and Computing, Kingston University, Kingston-upon-Thames, Surrey, United Kingdom ; King's College London British Heart Foundation Centre, Cardiovascular Division, The Rayne Institute, St Thomas' Hospital, London, United Kingdom.
St Thomas' Hospital · GBKing's College London · GBKingston University · GB

Funding

British Heart Foundation
6 · The paper itself

Abstract

The enzymatic activity of the type 2A protein phosphatase (PP2A) holoenzyme, a major serine/threonine phosphatase in the heart, is conferred by its catalytic subunit (PP2AC). PP2AC activity and subcellular localisation can be regulated by reversible carboxylmethylation of its C-terminal leucine309 (leu309) residue. Previous studies have shown that the stimulation of adenosine type 1 receptors (A1.Rs) induces PP2AC carboxylmethylation and altered subcellular distribution in adult rat ventricular myocytes (ARVM). In the current study, we show that the enzymatic components that regulate the carboxylmethylation status of PP2AC, leucine carboxylmethyltransferase-1 (LCMT-1) and phosphatase methylesterase-1 (PME-1) are abundantly expressed in, and almost entirely localised in the cytoplasm of ARVM. The stimulation of Gi-coupled A1.Rs with N(6)-cyclopentyladenosine (CPA), and of other Gi-coupled receptors such as muscarinic M2 receptors (stimulated with carbachol) and angiotensin II AT2 receptors (stimulated with CGP42112) in ARVM, induced PP2AC carboxylmethylation at leu309 in a concentration-dependent manner. Exposure of ARVM to 10 µM CPA increased the cellular association between PP2AC and its methyltransferase LCMT-1, but not its esterase PME-1. Stimulation of A1.Rs with 10 µM CPA increased the phosphorylation of protein kinase B at ser473, which was abolished by the PI3K inhibitor LY294002 (20 µM), thereby confirming that PI3K activity is upregulated in response to A1.R stimulation by CPA in ARVM. A1.R-induced PP2AC translocation to the particulate fraction was abrogated by adenoviral expression of the alpha subunit (Gαt1) coupled to the transducin G-protein coupled receptor. A similar inhibitory effect on A1.R-induced PP2AC translocation was also seen with LY294002 (20 µM). These data suggest that in ARVM, A1.R-induced PP2AC translocation to the particulate fraction occurs through a GiPCR-Gβγ-PI3K mediated intracellular signalling pathway, which may involve elevated PP2AC carboxylmethylation at leu309.

Indexed as

AdenosineAnalysis of VarianceAnimalsBlotting, WesternChromonesCytoplasmImmunoprecipitationMethylationMorpholinesMyocytes, CardiacPhosphatidylinositol 3-KinasesPhosphorylationProtein O-MethyltransferaseProtein Phosphatase 2Proto-Oncogene Proteins c-aktRats2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAdenosineChromonesMorpholinesN(6)-cyclopentyladenosinePhosphatidylinositol 3-KinasesPpp2ca protein, ratProtein O-MethyltransferaseProtein Phosphatase 2Proto-Oncogene Proteins c-aktReceptors, AngiotensinReceptors, G-Protein-Coupled

Identifiers

PMID24475092
PMCPMC3903491
OpenAlexW2154030935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.